Online citations, reference lists, and bibliographies.
← Back to Search

Nanoparticles And The Blood Coagulation System. Part II: Safety Concerns.

A. Ilinskaya, M. Dobrovolskaia
Published 2013 · Materials Science, Medicine
Referenced 1 time by Citationsy Users

Cite This
Download PDF
Analyze on Scholarcy
Share
Nanoparticle interactions with the blood coagulation system can be beneficial or adverse depending on the intended use of a nanomaterial. Nanoparticles can be engineered to be procoagulant or to carry coagulation-initiating factors to treat certain disorders. Likewise, they can be designed to be anticoagulant or to carry anticoagulant drugs to intervene in other pathological conditions in which coagulation is a concern. An overview of the coagulation system was given and a discussion of a desirable interface between this system and engineered nanomaterials was assessed in part I, which was published in the May 2013 issue of Nanomedicine. Unwanted pro- and anti-coagulant properties of nanoparticles represent significant concerns in the field of nanomedicine, and often hamper the development and transition into the clinic of many promising engineered nanocarriers. This part will focus on the undesirable effects of engineered nanomaterials on the blood coagulation system. We will discuss the relationship between the physicochemical properties of nanoparticles (e.g., size, charge and hydrophobicity) that determine their negative effects on the blood coagulation system in order to understand how manipulation of these properties can help to overcome unwanted side effects.
This paper references
10.2217/nnm.10.65
Procoagulant properties of bare and highly PEGylated vinyl-modified silica nanoparticles.
R. Tavano (2010)
10.1055/S-0038-1647003
Interactions of liposomes and platelets.
L. W. Reinish (1988)
10.1161/01.CIR.0000118524.62298.E8
Ultrafine Particles Exert Prothrombotic but Not Inflammatory Effects on the Hepatic Microcirculation in Healthy Mice In Vivo
A. Khandoga (2004)
10.1088/0957-4484/23/4/045101
Amorphous nanosilicas induce consumptive coagulopathy after systemic exposure.
H. Nabeshi (2012)
10.1002/ijc.27528
Quantum dots hold promise for early cancer imaging and detection
Pericles Pericleous (2012)
10.2217/nnm.11.105
Dendrimer-induced leukocyte procoagulant activity depends on particle size and surface charge.
M. Dobrovolskaia (2012)
10.2147/IJN.S25071
Amorphous silica nanoparticles trigger nitric oxide/peroxynitrite imbalance in human endothelial cells: inflammatory and cytotoxic effects
J. Corbalan (2011)
10.3109/17435390903470093
Pulmonary thrombosis in the mouse following intravenous administration of quantum dot-labeled mesenchymal cells
Y. Ramot (2010)
10.1002/smll.200800461
Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells.
D. Napierska (2009)
10.1074/jbc.M111.251884
Pulmonary Biocompatibility Assessment of Inhaled Single-wall and Multiwall Carbon Nanotubes in BALB/c Mice*
P. Ravichandran (2011)
10.1016/J.TOXLET.2006.11.001
Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants.
K. Pulskamp (2007)
10.1016/j.nano.2011.12.001
Polystyrene nanoparticles affecting blood coagulation.
C. Oslakovic (2012)
10.1021/mp200463e
Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro.
M. Dobrovolskaia (2012)
10.1166/JNN.2010.2681
Bioeffects of CdTe quantum dots on human umbilical vein endothelial cells.
L. Wang (2010)
10.1016/j.tox.2009.08.011
Single-walled carbon nanotubes activate platelets and accelerate thrombus formation in the microcirculation.
P. Bihari (2010)
10.1002/smll.201101422
Interactions of human endothelial cells with gold nanoparticles of different morphologies.
D. Bartczak (2012)
10.1093/TOXSCI/KFI142
The rat ear vein model for investigating in vivo thrombogenicity of ultrafine particles (UFP).
V. Silva (2005)
10.1289/ehp.11566
Acute Toxicity and Prothrombotic Effects of Quantum Dots: Impact of Surface Charge
J. Geys (2008)
10.1166/JNN.2011.3571
Fibrinogen clot induced by gold-nanoparticle in vitro.
G. Chen (2011)
10.2217/nnm.12.38
Research Highlights Highlights from the latest articles in nanomedicine
I. Rubinstein (2012)
10.1152/AJPLUNG.00419.2002
Involvement of reactive oxygen species in the metabolic pathways triggered by diesel exhaust particles in human airway epithelial cells.
A. Baulig (2003)
10.1111/j.1538-7836.2010.03904.x
Platelet adhesion and fibrinogen deposition in murine microvessels upon inhalation of nanosized carbon particles
A. Khandoga (2010)
10.1097/00000539-200003000-00004
A Second-Generation Blood Substitute (Perfluorodichlorooctane Emulsion) Generates Spurious Elevations in Platelet Counts from Automated Hematology Analyzers
O. Cuignet (2000)
10.1006/TAAP.1999.8762
Inflammatory effect of intratracheal instillation of ultrafine particles in the rabbit: role of C-fiber and mast cells.
A. Nemmar (1999)
10.2147/IJN.S28293
Amorphous silica nanoparticles aggregate human platelets: potential implications for vascular homeostasis
J. Corbalan (2012)
10.1002/ijc.11108
Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels
S. Krasnici (2003)
10.1081/BIO-120025410
Liposomes and Blood Cells: A Flow Cytometric Study
I. Constantinescu (2003)
10.2217/nnm.11.33
Iron core/shell nanoparticles as magnetic drug carriers: possible interactions with the vascular compartment.
I. Herrmann (2011)
10.1021/nn900918w
Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs.
T. Xia (2009)
10.1002/SMLL.200700005
Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs.
J. Lu (2007)
10.1016/j.otohns.2006.08.006
Propofol versus sevoflurane: Bleeding in endoscopic sinus surgery
A. Beule (2007)
10.1016/j.nano.2011.01.007
Multistability in platelets and their response to gold nanoparticles.
Suryyani Deb (2011)
10.1007/s11095-005-7547-7
Blood Compatibility of Cetyl Alcohol/Polysorbate-Based Nanoparticles
J. Koziara (2005)
10.1164/AJRCCM.159.3.9709083
Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers.
S. Salvi (1999)
10.1093/TOXSCI/KFG243
Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation.
C. Lam (2004)
10.1080/08958370290084881
CARDIOVASCULAR EFFECTS ASSOCIATED WITH AIR POLLUTION: POTENTIAL MECHANISMS AND METHODS OF TESTING
M. Utell (2002)
10.1016/j.colsurfb.2010.08.048
Negative regulation of fibrin polymerization and clot formation by nanoparticles of silver.
S. Shrivastava (2011)
10.1016/j.tox.2008.02.011
Comparative study of pulmonary responses to nano- and submicron-sized ferric oxide in rats.
Mo-Tao Zhu (2008)
10.1253/CIRCJ.70.129
Mechanisms underlying nano-sized air-pollution-mediated progression of atherosclerosis: carbon black causes cytotoxic injury/inflammation and inhibits cell growth in vascular endothelial cells.
H. Yamawaki (2006)
10.1093/toxsci/kfq349
Surface derivatization state of polystyrene latex nanoparticles determines both their potency and their mechanism of causing human platelet aggregation in vitro.
Catherine McGuinnes (2011)
10.1007/s11051-010-9911-8
Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?
A. AlKilany (2010)
10.1016/j.biomaterials.2012.01.005
The antithrombotic and antimicrobial properties of PEG-protected silver nanoparticle coated surfaces.
V. M. Ragaseema (2012)
10.1097/MCP.0b013e328013f47e
Particulate matter in the environment: pulmonary and cardiovascular effects
E. Alfaro-Moreno (2007)
10.1006/BBRC.1996.1014
Interaction of RGD liposomes with platelets.
T. Nishiya (1996)
10.2217/nnm.13.48
Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology.
A. Ilinskaya (2013)
10.1016/j.tox.2009.01.015
The role of nanoparticle size in hemocompatibility.
A. Mayer (2009)
A microanalytic study of particles transport across the alveoli: role of blood platelets.
J. P. Berry (1977)
10.1021/mp2006054
Cationic PAMAM dendrimers disrupt key platelet functions.
Clinton F Jones (2012)
10.3109/10731199209119758
Retention of perfluorochemicals in rat liver and spleen.
K. C. Lowe (1992)
10.1038/sj.bjp.0706386
Nanoparticle‐induced platelet aggregation and vascular thrombosis
Anna Radomski (2005)
10.1002/smll.200900466
Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage.
Y. Pan (2009)
10.1021/nn201950e
Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis.
S. Tenzer (2011)
10.3109/17435390.2010.506250
Silver nanoparticles enhance thrombus formation through increased platelet aggregation and procoagulant activity
Eun-Ah Jun (2011)
10.1164/RCCM.200507-1123OC
Air pollution and markers of inflammation and coagulation in patients with coronary heart disease.
R. Rueckerl (2006)
10.3109/10731199509117966
Mechanistic study on toxicity of positively charged liposomes containing stearylamine to blood.
T. Nishiya (1995)
10.1055/s-0030-1254046
Disseminated intravascular coagulation in infectious disease.
M. Levi (2010)
10.1038/nmat2442
Understanding biophysicochemical interactions at the nano-bio interface.
A. Nel (2009)
10.1056/NEJMra0801082
Mechanisms of thrombus formation.
B. Furie (2008)
10.1093/TOXSCI/KFG228
Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats.
D. Warheit (2004)
10.1097/00004311-198502310-00016
Present Status of Clinical Studies of Fluosol‐DA (20%) in Japan
T. Mitsuno (1985)
10.1016/j.biomaterials.2011.04.059
Determinants of the thrombogenic potential of multiwalled carbon nanotubes.
A. Burke (2011)
10.1161/01.CIR.0000053568.13058.67
Diesel Exhaust Particles in Lung Acutely Enhance Experimental Peripheral Thrombosis
A. Nemmar (2003)
10.1007/s002040100266
Health hazards due to the inhalation of amorphous silica
R. Merget (2001)
Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors.
R. Campbell (2002)
10.1016/j.addr.2009.03.009
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.
P. Aggarwal (2009)
10.1016/j.biomaterials.2009.05.044
Blood coagulation on biomaterials requires the combination of distinct activation processes.
C. Sperling (2009)
10.1161/CIR.0b013e3181dbece1
Particulate Matter Air Pollution and Cardiovascular Disease: An Update to the Scientific Statement From the American Heart Association
R. Brook (2010)
10.1016/j.biomaterials.2011.07.078
Cytotoxicity of silica nanoparticles through exocytosis of von Willebrand factor and necrotic cell death in primary human endothelial cells.
A. Bauer (2011)
10.1073/PNAS.89.19.9191
Phagocytosis of liposomes by human platelets.
R. Male (1992)
10.3109/17435390.2011.604442
Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticles
K. Greish (2012)
10.1016/j.taap.2009.02.018
Potential in vitro effects of carbon nanotubes on human aortic endothelial cells.
Valerie G Walker (2009)
10.1001/archinte.168.9.920
Exposure to particulate air pollution and risk of deep vein thrombosis.
A. Baccarelli (2008)
10.1016/S0168-3659(99)00246-1
Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.
N. Malik (2000)
10.1164/AJRCCM.161.2.9905052
Acute exposure to diesel exhaust increases IL-8 and GRO-alpha production in healthy human airways.
S. Salvi (2000)
10.1016/0300-483X(89)90063-2
Assessment of thrombogenic potential of liposomes.
G. Zbinden (1989)
10.1136/oem.2006.032458
Experimental exposure to wood smoke: effects on airway inflammation and oxidative stress
L. Barregård (2007)
10.1016/j.taap.2008.09.012
Size effects of latex nanomaterials on lung inflammation in mice.
K. Inoue (2009)
10.1016/0014-4827(83)90144-1
Interactions of conventional or photopolymerized liposomes with platelets in vitro.
R. Juliano (1983)
10.1152/AJPLUNG.00084.2005
Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice.
A. Shvedova (2005)
10.1007/s00204-005-0668-2
Pulmonary exposure to diesel exhaust particles induces airway inflammation and cytokine expression in NC/Nga mice
K. Inoue (2005)
10.1016/J.TOXLET.2003.12.061
Possible mechanisms of the cardiovascular effects of inhaled particles: systemic translocation and prothrombotic effects.
A. Nemmar (2004)
10.1080/08958370390249111
Exposure to Concentrated Ambient Air Particles Alters Hematologic Indices in Humans
A. Ghio (2003)
10.1161/HC0402.104118
Passage of Inhaled Particles Into the Blood Circulation in Humans
A. Nemmar (2002)
10.1021/nn900277t
Characterization of antiplatelet properties of silver nanoparticles.
Siddhartha S Shrivastava (2009)
10.1021/nl801828z
Cross-talk between lung and systemic circulation during carbon nanotube respiratory exposure. Potential biomarkers.
A. Erdely (2009)
10.1016/j.biomaterials.2010.07.069
Endothelial cells dysfunction induced by silica nanoparticles through oxidative stress via JNK/P53 and NF-kappaB pathways.
X. Liu (2010)
10.1111/j.1365-2044.2008.05672.x
Spurious propofol‐induced coagulopathy in a patient with hepatic rupture
H. Thomson (2008)
10.1038/sj.jea.7500408
Association of criteria pollutants with plasma hemostatic/inflammatory markers: a population-based study
D. Liao (2005)
10.1021/BM7008203
Cytotoxicity of polypropylenimine dendrimer conjugates on cultured endothelial cells.
N. Stasko (2007)
10.1016/j.nano.2008.08.001
Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles.
M. Dobrovolskaia (2009)
10.1098/rsif.2009.0021
Nanoparticles of a different source induce different patterns of activation in key biochemical and cellular components of the host response
A. Guildford (2009)
10.1016/j.jconrel.2009.05.035
Contact activation of kallikrein-kinin system by superparamagnetic iron oxide nanoparticles in vitro and in vivo.
D. Simberg (2009)
10.1021/nl901603k
Carbon nanotubes activate blood platelets by inducing extracellular Ca2+ influx sensitive to calcium entry inhibitors.
Jana Šemberová (2009)
10.1021/nn2015369
Carbon nanotubes activate store-operated calcium entry in human blood platelets.
S. Lacerda (2011)
10.1182/blood.v59.6.1299.1299
Activation of plasma complement by perfluorocarbon artificial blood: probable mechanism of adverse pulmonary reactions in treated patients and rationale for corticosteroids prophylaxis.
G. Vercellotti (1982)
10.1016/j.tox.2011.01.015
An in vitro study of vascular endothelial toxicity of CdTe quantum dots.
Ming Yan (2011)
10.1007/s12199-010-0177-7
Promoting effects of nanoparticles/materials on sensitive lung inflammatory diseases
K. Inoue (2011)
10.1016/j.freeradbiomed.2008.01.028
The role of oxidative stress in ambient particulate matter-induced lung diseases and its implications in the toxicity of engineered nanoparticles.
N. Li (2008)
10.1080/10623320802228583
Importance of the liposomal cationic lipid content and type in tumor vascular targeting: physicochemical characterization and in vitro studies using human primary and transformed endothelial cells.
Sudhir Dabbas (2008)
10.1073/pnas.0805135105
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts
M. Lundqvist (2008)
10.1100/tsw.2011.44
Aggravating Impact of Nanoparticles on Immune-Mediated Pulmonary Inflammation
K. Inoue (2011)
10.1021/NL060860Z
The importance of an endotoxin-free environment during the production of nanoparticles used in medical applications.
H. Vallhov (2006)
10.1164/RCCM.200506-865OC
Do inhaled carbon nanoparticles translocate directly into the circulation in humans?
N. Mills (2006)
10.1152/AJPLUNG.00055.2005
Diesel exhaust activates redox-sensitive transcription factors and kinases in human airways.
J. Pourazar (2005)



This paper is referenced by
10.1021/acsami.5b11619
An MMP-2 Responsive Liposome Integrating Antifibrosis and Chemotherapeutic Drugs for Enhanced Drug Perfusion and Efficacy in Pancreatic Cancer.
T. Ji (2016)
10.1039/D0AY00170H
The characterization of self-assembled nanostructures in whole blood
M. Pitman (2020)
10.2217/nnm.13.48
Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology.
A. Ilinskaya (2013)
10.1155/2016/2959414
Silica Nanoparticles Effects on Blood Coagulation Proteins and Platelets
V. Gryshchuk (2016)
10.1039/d0bm00781a
Hemostatic nanotechnologies for external and internal hemorrhage management.
L. Wang (2020)
10.3109/17435390.2014.992815
Effects of acute systemic administration of TiO2, ZnO, SiO2, and Ag nanoparticles on hemodynamics, hemostasis and leukocyte recruitment
Nadine Haberl (2015)
10.1039/c9cs00309f
Nanoparticles' interactions with vasculature in diseases.
J. K. Tee (2019)
10.1007/978-3-319-99602-8_10
Nanoparticles in Nanomedicine Application: Lipid-Based Nanoparticles and Their Safety Concerns
R. B. S. Mydin (2019)
Nanoparticules d'or à couronne polymère modulable : synthèse, interactions avec les systèmes biologiques et propriétés de radiosensibilisation
Marine Le Goas (2019)
10.2217/nnm.14.77
Flow cytometric analysis of the physical and protein-binding characteristics of solid drug nanoparticle suspensions.
N. Liptrott (2015)
10.1002/jin2.34
Identification of regulatory needs for nanomedicines
S. Bremer-Hoffmann (2018)
10.1007/978-3-319-76708-6_1
Nanoparticle Uptake by Plants: Beneficial or Detrimental?
I. Pacheco (2018)
10.1557/JMR.2019.176
Exploration of interactions of ‘blood-nano interface’ of carbon-based nanomaterials for biomedical applications
Vishal Singh (2019)
10.1007/978-3-662-59600-5_3
Evaluation of Biodistribution, Toxicology, and Toxicologic Pathology of Nanomaterials Used to Deliver Nucleic Acids
H. D. Liggitt (2019)
10.1016/j.cbpc.2018.11.003
Integrative meta-analysis of publically available microarray datasets of several epithelial cell lines identifies biological processes affected by silver nanoparticles exposure.
S. Ghojavand (2019)
10.3390/nano9081153
Luminescence and X-ray Absorption Properties of Uniform Eu3+:(H3O)Lu3F10 Nanoprobes
Daniel González-Mancebo (2019)
Nanotoxicology of Nanomaterials : New Opportunities and Challenges
A. Radomska (2016)
10.1039/C7RA00687J
Controlling structural and magnetic properties of IONPs by aqueous synthesis for improved hyperthermia
D. Bonvin (2017)
10.1002/APP.48234
Iron oxide nanoparticles improved biocompatibility and removal of middle molecule uremic toxin of polysulfone hollow fiber membranes
N. Said (2019)
10.25148/etd.FIDC001251
Magnetoelectric Nanoparticles: Paradigm Shift in Biomolecular Diagnostics
Chooda Khanal (2016)
10.3390/nano10040656
Systemic Review of Biodegradable Nanomaterials in Nanomedicine
S. Su (2020)
10.1002/wnan.1665
Challenges in the development of nanoparticle-based imaging agents: Characterization and biology.
Rachael M Crist (2020)
10.1039/c6bm00954a
Magnetic nanoparticles for drug targeting: from design to insights into systemic toxicity. Preclinical evaluation of hematological, vascular and neurobehavioral toxicology.
M. Agotegaray (2017)
10.1016/j.colsurfb.2015.10.047
Impact of poly(lactic-co-glycolic acid) nanoparticle surface charge on protein, cellular and haematological interactions.
Gopikrishna J. Pillai (2015)
10.1016/j.addr.2018.06.023
Unintended effects of drug carriers: Big issues of small particles
H. Parhiz (2018)
10.1039/c5nr00290g
Smart doxorubicin nanoparticles with high drug payload for enhanced chemotherapy against drug resistance and cancer diagnosis.
Caitong Yu (2015)
10.1142/9789813140455_0008
Nanoparticles and the Blood Coagulation System
A. Ilinskaya (2016)
10.7939/R3N873D18
The Effects of Liposome Treatment on Red Blood Cells during Hypothermic Storage
L. Cavalcante (2017)
10.1002/anie.201506262
Transformable Peptide Nanocarriers for Expeditious Drug Release and Effective Cancer Therapy via Cancer‐Associated Fibroblast Activation
T. Ji (2016)
10.1186/s12951-018-0357-y
Vascular biosafety of commercial hydroxyapatite particles: discrepancy between blood compatibility assays and endothelial cell behavior
Catarina Santos (2018)
10.1039/c9nj04608a
Ag2S-Glutathione quantum dots for NIR image guided photothermal therapy
M. Hashemkhani (2020)
10.3390/pharmaceutics11080395
Oxaliplatin–Biomimetic Magnetic Nanoparticle Assemblies for Colon Cancer-Targeted Chemotherapy: An In Vitro Study
Ylenia Jabalera (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar